Cardiac structure, function and exercise capacity in long-term survivors of acute lymphoblastic leukaemia

Clicks: 1
ID: 323274
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #196 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Survival after acute lymphoblastic leukaemia (ALL) now exceeds 90% following intensive chemotherapy. Anthracyclines remain integral to treatment but are associated with chemotherapy-related cardiac dysfunction (CTRCD), ranging from subclinical myocardial impairment to overt heart failure. Conventional surveillance relies primarily on two-dimensional (2D) left ventricular ejection fraction (LVEF), which may be insufficiently sensitive to detect early or subtle myocardial changes. Advanced echocardiographic techniques and cardiopulmonary exercise testing (CPET) may improve long-term cardiovascular risk assessment in cancer survivors. Purpose To evaluate long-term cardiac structure, function and exercise capacity in survivors of ALL using advanced echocardiography and CPET, and to compare findings with non-exposed controls. Methods In this cross-sectional study, survivors of ALL diagnosed between 2008 and 2018 were included together with age- and sex-matched controls without prior exposure to chemotherapy. Transthoracic echocardiography was performed, including tissue Doppler imaging, speckle-tracking echocardiography (global longitudinal strain, GLS) and three-dimensional (3D) volumetric assessment. Cardiac chamber sizes were indexed to body surface area. Cardiorespiratory fitness was assessed using symptom-limited CPET on a cycle ergometer, with peak oxygen uptake (VO2peak) as the primary exercise endpoint. Results A total of 291 survivors (median 6.9 years since diagnosis) and 332 controls completed echocardiography and CPET. Survivors demonstrated modest but consistent reductions in left ventricular systolic function assessed by 2D LVEF (53.8 ± 4.9% vs 55.0 ± 4.7%, p = 0.004), GLS (-17.4 ± 2.2% vs -18.1 ± 2.2%, p < 0.001) and 3D LVEF (54.6 ± 7.4% vs 56.4 ± 6.7%, p = 0.004). Right ventricular systolic function was also reduced, with lower tricuspid annular plane systolic excursion (21.7 ± 3.7 mm vs 23.4 ± 4.2 mm, p < 0.001). Survivors had smaller indexed cardiac chamber volumes (all p < 0.001). Exercise capacity was significantly impaired in survivors, with lower VO2peak compared with controls (34.6 ± 8.1 vs 41.6 ± 7.9 mL/kg/min, p < 0.001). Mean BMI values in both groups were within the normal range according to age-specific reference standards; however, survivors had a significantly higher BMI than controls as well as higher waist-to-height ratio. Conclusion Long-term survivors of ALL demonstrated only subtle differences in echocardiographic parameters including smaller cardiac dimensions, marginally reduced biventricular systolic function as well as reduced exercise capacity compared with non-exposed controls. Survivors had higher waist-to-height ratio and were less physical active. The observed findings may reflect chemotherapy-related cardiac dysfunction or alternatively represents physical deconditioning. Further longitudinal studies are required to further clarify causality and clinical implications.
Reference Key
openalex_W7172351007 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors P H Johnsen, C A Frederiksen, S H Poulsen, B K Albertsen, G Wood, S Riddersholm, T L Frandsen, L Andres-Jensen, K A A Myhr, K Schmeigelow, S L M Rubak, M T Skipper, W Y Kim
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.047
URL
https://doi.org/10.1093/eurheartjsupp/suag097.047
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.